The central nervous system as target of Bacillus anthracis toxin independent virulence in rabbits and guinea pigs.
Infection of the central nervous system is considered a complication of Anthrax and was reported in humans and non-human primates. Previously we have reported that Bacillus anthracis possesses a toxin-independent virulent trait that, like the toxins, is regulated by the major virulence regulator, AtxA, in the presence of pXO2. This toxin-independent lethal trait is exhibited in rabbits and Guinea pigs following significant bacteremia and organ dissemination. Various findings, including meningitis seen in humans and primates, suggested that the CNS is a possible target for this AtxA-mediated activity. In order to penetrate into the brain tissue, the bacteria have to overcome the barriers isolating the CNS from the blood stream. Taking a systematic genetic approach, we compared intracranial (IC) inoculation and IV/SC inoculation for the outcome of the infection in rabbits/GP, respectively. The outstanding difference between the two models is exhibited by the encapsulated strain VollumΔpXO1, which is lethal when injected IC, but asymptomatic when inoculated IV/SC. The findings demonstrate that there is an apparent bottleneck in the ability of mutants to penetrate into the brain. Any mutant carrying either pXO1 or pXO2 will kill the host upon IC injection, but only those carrying AtxA either on pXO1 or in the chromosome in the background of pXO2 can penetrate into the brain following peripheral inoculation. The findings were corroborated by histological examination by H&E staining and immunofluorescence of rabbits' brains following IV and IC inoculations. These findings may have major implications on future research both on B. anthracis pathogenicity and on vaccine development.
Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Haim
H
Levy
Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Itai
I
Glinert
Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Shay
S
Weiss
Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Elad
E
Bar-David
Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Assa
A
Sittner
Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Josef
J
Schlomovitz
Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Zeev
Z
Altboum
Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
David
D
Kobiler
D000818:Animals; D000881:Anthrax / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D000942:Antigens, Bacterial / Q000235:genetics / Q000378:metabolism; D001408:Bacillus anthracis / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D002876:Chromosomes, Bacterial / Q000235:genetics / Q000378:metabolism; D006168:Guinea Pigs; D006801:Humans; D011817:Rabbits; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism
C082932:ATXA protein, Bacillus anthracis; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D015534:Trans-Activators; C030325:anthrax toxin